<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>RxTrace</title>
	
	<link>http://www.rxtrace.com</link>
	<description>A comprehensive exploration of the intersection between the pharmaceutical supply chain, track and trace technology, standards and regulatory compliance</description>
	<lastBuildDate>Mon, 21 May 2012 09:52:18 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/rxtrace/vqly" /><feedburner:info uri="rxtrace/vqly" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><creativeCommons:license>http://creativecommons.org/licenses/by-nd/2.0/</creativeCommons:license><feedburner:emailServiceId>rxtrace/vqly</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item>
		<title>Before You Sign Up For GDSN, Get Your Data In Order With A Data Quality Program</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/8WxFPWPHEu0/</link>
		<comments>http://www.rxtrace.com/2012/05/before-you-sign-up-for-gdsn-get-your-data-in-order-with-a-data-quality-program.html/#comments</comments>
		<pubDate>Mon, 21 May 2012 09:52:18 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[Data Quality]]></category>
		<category><![CDATA[GDSN]]></category>
		<category><![CDATA[GLN]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[GTIN]]></category>
		<category><![CDATA[master data]]></category>
		<category><![CDATA[SCMD]]></category>
		<category><![CDATA[supply chain master data]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2444</guid>
		
			<content:encoded><![CDATA[Last week I published an essay that gave GS1 some advice on how to trigger interest in adoption of their Global Data Synchronization Network (GDSN).  Those of you who read that essay in the first two days read my snarky comments about GS1 seemingly attempting to commandeer the term “Data Quality” to include the need [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/8WxFPWPHEu0" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/05/before-you-sign-up-for-gdsn-get-your-data-in-order-with-a-data-quality-program.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/05/before-you-sign-up-for-gdsn-get-your-data-in-order-with-a-data-quality-program.html/</feedburner:origLink></item>
		<item>
		<title>An Open Letter to GS1, RE:  GDSN Marketing</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/AywrnDe6F1U/</link>
		<comments>http://www.rxtrace.com/2012/05/an-open-letter-to-gs1-re-gdsn-marketing.html/#comments</comments>
		<pubDate>Mon, 14 May 2012 09:38:39 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[GDSN]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[master data]]></category>
		<category><![CDATA[supply chain master data]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2427</guid>
		
			<content:encoded><![CDATA[Dear GS1, How have you been?  I’ve been fine, done a bit of writing since we last met and gotten a little greyer.  How are the kids?  My two kids are doing great but I have to admit, after raising two I don’t know how you do it with 125 kids, or whatever the number [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/AywrnDe6F1U" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/05/an-open-letter-to-gs1-re-gdsn-marketing.html/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/05/an-open-letter-to-gs1-re-gdsn-marketing.html/</feedburner:origLink></item>
		<item>
		<title>James “Jim” Dowden (1955? – 2012)</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/LXwj4lgtXsg/</link>
		<comments>http://www.rxtrace.com/2012/05/james-jim-dowden-1955-2012.html/#comments</comments>
		<pubDate>Thu, 10 May 2012 23:57:29 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[Sad News]]></category>
		<category><![CDATA[Jim Dowden]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2418</guid>
		
			<content:encoded><![CDATA[I received word last night that our friend Jim Dowden passed away unexpectedly on Saturday.  I know many RxTrace readers knew him in one capacity or another.  See his obituary here.  Most recently Jim was Head of Logistics Management, North America for Genentech.  When I first met him back in the mid-2000&#8242;s he worked for [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/LXwj4lgtXsg" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/05/james-jim-dowden-1955-2012.html/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/05/james-jim-dowden-1955-2012.html/</feedburner:origLink></item>
		<item>
		<title>The Built-in Protections Of The U.S. Pharma Supply Chain</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/JFhE9qn1vcA/</link>
		<comments>http://www.rxtrace.com/2012/05/the-built-in-protections-of-the-u-s-pharma-supply-chain.html/#comments</comments>
		<pubDate>Mon, 07 May 2012 09:17:18 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[pharmaceutical supply chain]]></category>
		<category><![CDATA[California Pedigree Law]]></category>
		<category><![CDATA[cargo theft]]></category>
		<category><![CDATA[Counterfeit Drugs]]></category>
		<category><![CDATA[crimes]]></category>
		<category><![CDATA[Criminal penalties]]></category>
		<category><![CDATA[Dangerous Doses]]></category>
		<category><![CDATA[Eli Lilly warehouse theft]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Florida Pedigree Law]]></category>
		<category><![CDATA[Katherine Eban]]></category>
		<category><![CDATA[legitimate pharmaceutical supply chain]]></category>
		<category><![CDATA[PDMA]]></category>
		<category><![CDATA[pedigree]]></category>
		<category><![CDATA[pedigree laws]]></category>
		<category><![CDATA[protections]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2397</guid>
		
			<content:encoded><![CDATA[Last week we learned that 11 people were charged with the record-breaking $75 Million drug heist from the Eli Lilly warehouse in Enfield, Connecticut back in March of 2010 (see the excellent article by Jay Weaver in the Miami Herald, including a copy of one of the multiple indictments).  Importantly, all of the stolen drugs [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/JFhE9qn1vcA" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/05/the-built-in-protections-of-the-u-s-pharma-supply-chain.html/feed/</wfw:commentRss>
		<slash:comments>12</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/05/the-built-in-protections-of-the-u-s-pharma-supply-chain.html/</feedburner:origLink></item>
		<item>
		<title>The Serial Number Handling In Your WMS Probably Isn’t Sufficient For Pharma Serialization</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/xKUaMm1Bq3w/</link>
		<comments>http://www.rxtrace.com/2012/04/the-serial-number-handling-in-your-wms-probably-isnt-sufficient-for-pharma-serialization.html/#comments</comments>
		<pubDate>Mon, 30 Apr 2012 09:35:56 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[WMS]]></category>
		<category><![CDATA[Authentication]]></category>
		<category><![CDATA[California Pedigree Law]]></category>
		<category><![CDATA[DPMS]]></category>
		<category><![CDATA[EPCIS]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[GS1 General Specification]]></category>
		<category><![CDATA[GS1 U.S.]]></category>
		<category><![CDATA[GTIN]]></category>
		<category><![CDATA[pharmaceutical supply chain]]></category>
		<category><![CDATA[POD]]></category>
		<category><![CDATA[Point of Dispense]]></category>
		<category><![CDATA[serialization]]></category>
		<category><![CDATA[SNI]]></category>
		<category><![CDATA[standards]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2369</guid>
		
			<content:encoded><![CDATA[Most Warehouse Management Systems (WMS) available on the market today do a fine job of allowing their users to manage inventories in the warehouses of drug manufacturers, distributors and chain drug stores.  A WMS is a software system that may be a part of a larger Enterprise Resource Planning (ERP) system, or it may be [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/xKUaMm1Bq3w" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/04/the-serial-number-handling-in-your-wms-probably-isnt-sufficient-for-pharma-serialization.html/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/04/the-serial-number-handling-in-your-wms-probably-isnt-sufficient-for-pharma-serialization.html/</feedburner:origLink></item>
		<item>
		<title>Your GS1 Company Prefix:  An Enterprise Resource</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/fQWkWztUlg0/</link>
		<comments>http://www.rxtrace.com/2012/04/your-gs1-company-prefix-an-enterprise-resource.html/#comments</comments>
		<pubDate>Mon, 23 Apr 2012 09:53:20 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[GS1 Company Prefix]]></category>
		<category><![CDATA[GLN]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[GS1 General Specification]]></category>
		<category><![CDATA[GS1 U.S.]]></category>
		<category><![CDATA[GTIN]]></category>
		<category><![CDATA[NDC]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2353</guid>
		
			<content:encoded><![CDATA[Any company wishing to make use of GS1 standards—including their barcodes, identifiers and data exchange standards—must first obtain a GS1 Company Prefix, or “GCP”.  Normally you would obtain a GCP by applying to the GS1 Member Organization (M.O.) in the country where your company headquarters resides, but if you are a pharmaceutical company that makes [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/fQWkWztUlg0" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/04/your-gs1-company-prefix-an-enterprise-resource.html/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/04/your-gs1-company-prefix-an-enterprise-resource.html/</feedburner:origLink></item>
		<item>
		<title>Should FDA Cede All Standards Development To GS1?</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/UE_WIdplRyA/</link>
		<comments>http://www.rxtrace.com/2012/04/should-fda-cede-all-standards-development-to-gs1.html/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 09:21:34 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[Authentication]]></category>
		<category><![CDATA[EPCIS]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[pharmaceutical supply chain]]></category>
		<category><![CDATA[SGTIN]]></category>
		<category><![CDATA[SNI]]></category>
		<category><![CDATA[track and trace]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2338</guid>
		
			<content:encoded><![CDATA[Back in 2007 the U.S. Congress passed the Food and Drug Administration Amendments Act (FDAAA) and it was signed into law by President Bush.  One of the provisions of that law was an instruction to the FDA to “…develop standards and identify and validate effective technologies for the purpose of securing the drug supply chain [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/UE_WIdplRyA" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/04/should-fda-cede-all-standards-development-to-gs1.html/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/04/should-fda-cede-all-standards-development-to-gs1.html/</feedburner:origLink></item>
		<item>
		<title>InBrief: ePedigree Models and Points of Failure</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/7H8UtgtNN10/</link>
		<comments>http://www.rxtrace.com/2012/04/inbrief-epedigree-models-and-points-of-failure.html/#comments</comments>
		<pubDate>Tue, 10 Apr 2012 09:54:09 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[Pedigree models]]></category>
		<category><![CDATA[distributed pedigree]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[legitimate pharmaceutical supply chain]]></category>
		<category><![CDATA[pedigree models]]></category>
		<category><![CDATA[pharmaceutical supply chain]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2309</guid>
		
			<content:encoded><![CDATA[Over the last year in GS1, in many of the members of the U.S. pharma supply chain and even in the FDA, the focus has turned to the analysis and discussion of three classes of electronic pedigree models: Fully Centralized, Semi-Centralized, and Fully Distributed. I’ve discussed some of the pros and cons of these models [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/7H8UtgtNN10" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/04/inbrief-epedigree-models-and-points-of-failure.html/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/04/inbrief-epedigree-models-and-points-of-failure.html/</feedburner:origLink></item>
		<item>
		<title>GS1 Standards – Betcha Can’t Use Just One!</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/OVTX0s4cXG8/</link>
		<comments>http://www.rxtrace.com/2012/04/gs1-standards-betcha-cant-use-just-one.html/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 09:35:39 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[Pedigree models]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[DPMS]]></category>
		<category><![CDATA[EPCIS]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GDSN]]></category>
		<category><![CDATA[GLN]]></category>
		<category><![CDATA[GS1]]></category>
		<category><![CDATA[GTIN]]></category>
		<category><![CDATA[master data]]></category>
		<category><![CDATA[pedigree laws]]></category>
		<category><![CDATA[pedigree models]]></category>
		<category><![CDATA[pharmaceutical supply chain]]></category>
		<category><![CDATA[SCMD]]></category>
		<category><![CDATA[SNI]]></category>
		<category><![CDATA[supply chain master data]]></category>
		<category><![CDATA[track and trace]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2277</guid>
		
			<content:encoded><![CDATA[The title is a paraphrase of a TV commercial from the 1960&#8242;s, &#8217;70&#8242;s and &#8217;80&#8242;s for Lay&#8217;s Potato Chips but the sentiment is the same.  You really can&#8217;t get away with using only a single GS1 standard.  That&#8217;s why they are sometimes referred to as &#8220;The GS1 System of Standards&#8220;.  It&#8217;s a &#8220;system&#8221; of standards.  [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/OVTX0s4cXG8" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/04/gs1-standards-betcha-cant-use-just-one.html/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/04/gs1-standards-betcha-cant-use-just-one.html/</feedburner:origLink></item>
		<item>
		<title>InBrief:  FDA To Publish Track &amp; Trace Standard By Year End</title>
		<link>http://feedproxy.google.com/~r/rxtrace/vqly/~3/vZhJSbOG7R0/</link>
		<comments>http://www.rxtrace.com/2012/03/inbrief-fda-to-publish-track-trace-standard-by-year-end.html/#comments</comments>
		<pubDate>Wed, 28 Mar 2012 08:32:51 +0000</pubDate>
		<dc:creator>Dirk Rodgers</dc:creator>
				<category><![CDATA[Federal Pedigree]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[pedigree laws]]></category>
		<category><![CDATA[SNI]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[track and trace]]></category>

		<guid isPermaLink="false">http://www.rxtrace.com/?p=2256</guid>
		
			<content:encoded><![CDATA[I stumbled across the FDA’s recently published “Guidance Agenda:  New &#38; Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2012” while surfing the PharmTech website late last week.  The guide is published each year in the spring to provide a “heads-up” on which guidance documents the FDA thinks they will be able to [...]<br/>
<br/>
Click on the title to read my entire post!<img src="http://feeds.feedburner.com/~r/rxtrace/vqly/~4/vZhJSbOG7R0" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.rxtrace.com/2012/03/inbrief-fda-to-publish-track-trace-standard-by-year-end.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.rxtrace.com/2012/03/inbrief-fda-to-publish-track-trace-standard-by-year-end.html/</feedburner:origLink></item>
	</channel>
</rss><!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced
Database Caching 21/24 queries in 0.169 seconds using disk: basic

Served from: www.rxtrace.com @ 2012-05-21 08:13:39 -->

